article thumbnail

Why You Should Put Yourself Out There and Try New Products

Both Sides of the Table

In 2008 I started VC blogging. I had blogged when I was an entrepreneur. In 2011 I started using Instagram. In 2015 I opened up my Facebook page to the public. In 2007 I started using Twitter and most of my friends & colleagues wondered why people would care what I ate for lunch. I already have Facebook.”.

Snapchat 150
article thumbnail

Latest Data Show Venture Capital Industry on Pins and Needles

Xconomy

billion, 2,034 deals) and the third quarter of 2015 ($21.1 billion, 2,559 deals), signaling perhaps a period of digestion given how much had been invested during the 2014-2015 window. Notably, this was the lowest quarterly deal volume since the fourth quarter of 2011, a period spanning 19 quarters.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal

Xconomy

billion in revenue in 2015, most of which came from testing done at physician’s offices and other healthcare facilities. The company’s 2015 revenue was $128.2 In 2011, state incentives lured the company to Research Triangle Park, where it built a $19 million lab to bolster its molecular diagnostics business.

article thumbnail

Future of The Cloud is Bright | Just Ask the Market

Tech Zulu Event

Hulme, blogging at Cloud Commons , believes that the cloud will spur a jobs explosion, though the jobs descriptions will differ. An IDC study commissioned on behalf of Microsoft has shown that cloud computing will be responsible for creating nearly 14 million new jobs between 2011 and 2015.

article thumbnail

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

Xconomy

Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. Sales of both drugs, ivacaftor (Kalydeco) and the combo pill ivacaftor-lumacaftor (Orkambi), reached almost $1 billion in 2015 and are growing.

Startup 40
article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

Our list was far from definitive, but some noteworthy outcomes from last year’s selection suggest we’re taking the right approach: — Cypher Genomics , founded in 2011 with software to rapidly identify the genetic variations amid billions of gigabases of genome sequencing data, sold last November to San Diego’s Human Longevity.

article thumbnail

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

The firm raised $450 million in January 2015. . —Cambridge, MA-based messenger RNA drug developer Moderna Therapeutics is raising another huge financing round, according to an SEC filing. The firm has nabbed $451 million toward its goal of $600 million. He was a professor at UC San Diego.

News 57